Literature DB >> 28650207

Epicardial, pericardial and total cardiac fat and cardiovascular disease in type 2 diabetic patients with elevated urinary albumin excretion rate.

Regitse H Christensen1,2, Bernt J von Scholten1, Christian S Hansen1, Sarah E Heywood2, Jaya B Rosenmeier3, Ulrik B Andersen4, Peter Hovind4, Henrik Reinhard1, Hans-Henrik Parving5,6, Bente K Pedersen2, Marit E Jørgensen1,7, Peter K Jacobsen8, Peter Rossing1,6,9.   

Abstract

Background We evaluated the association of cardiac adipose tissue including epicardial adipose tissue and pericardial adipose tissue with incident cardiovascular disease and mortality, coronary artery calcium, carotid intima media thickness and inflammatory markers. Design A prospective study of 200 patients with type 2 diabetes and elevated urinary albumin excretion rate (UAER). Methods Cardiac adipose tissue was measured from baseline echocardiography. The composite endpoint comprised incident cardiovascular disease and all-cause mortality. Coronary artery calcium, carotid intima media thickness and inflammatory markers were measured at baseline. Cardiac adipose tissue was investigated as continuous and binary variable. Analyses were performed unadjusted (model 1), and adjusted for age, sex (model 2), body mass index, low-density lipoprotein cholesterol, smoking, glycated haemoglobin, and systolic blood pressure (model 3). Results Patients were followed-up after 6.1 years for non-fatal cardiovascular disease ( n = 29) or mortality ( n = 23). Cardiac adipose tissue ( p = 0.049) and epicardial adipose tissue ( p = 0.029) were associated with cardiovascular disease and mortality in model 1. When split by the median, patients with high cardiac adipose tissue had a higher risk of cardiovascular disease and mortality than patients with low cardiac adipose tissue in unadjusted (hazard ratio 1.9, confidence interval: 1.1; 3.4, p = 0.027) and adjusted (hazard ratio 2.0, confidence interval: 1.1; 3.7, p = 0.017) models. Cardiac adipose tissue ( p =  0.033) was associated with baseline coronary artery calcium (model 1) and interleukin-8 (models 1-3, all p < 0.039). Conclusions In type 2 diabetes patients without coronary artery disease, high cardiac adipose tissue levels were associated with increased risk of incident cardiovascular disease or all-cause mortality even after accounting for traditional cardiovascular disease risk factors. High cardiac adipose tissue amounts were associated with subclinical atherosclerosis (coronary artery calcium) and with the pro-atherogenic inflammatory marker interleukin-8.

Entities:  

Keywords:  Type 2 diabetes; cardiovascular disease; coronary artery calcium; epicardial fat; pericardial fat

Mesh:

Substances:

Year:  2017        PMID: 28650207     DOI: 10.1177/2047487317717820

Source DB:  PubMed          Journal:  Eur J Prev Cardiol        ISSN: 2047-4873            Impact factor:   7.804


  11 in total

Review 1.  Epicardial adipose tissue: new parameter for cardiovascular risk assessment in high risk populations.

Authors:  Roberta Russo; Biagio Di Iorio; Luca Di Lullo; Domenico Russo
Journal:  J Nephrol       Date:  2018-04-27       Impact factor: 3.902

2.  Effect of Aerobic and Resistance Exercise on Cardiac Adipose Tissues: Secondary Analyses From a Randomized Clinical Trial.

Authors:  Regitse Højgaard Christensen; Anne-Sophie Wedell-Neergaard; Louise Lang Lehrskov; Grit Elster Legaard; Emma Dorph; Monica Korsager Larsen; Natja Launbo; Sabrina Ravn Fagerlind; Sidsel Kofoed Seide; Stine Nymand; Maria Ball; Nicole Buchner Vinum; Camilla Nørfelt Dahl; Marie Henneberg; Mathias Ried-Larsen; Mikael Ploug Boesen; Robin Christensen; Kristian Karstoft; Rikke Krogh-Madsen; Jaya Birgitte Rosenmeier; Bente Klarlund Pedersen; Helga Ellingsgaard
Journal:  JAMA Cardiol       Date:  2019-08-01       Impact factor: 14.676

3.  Increased epicardial adipose tissue thickness is a predictor of new-onset diabetes mellitus in patients with coronary artery disease treated with high-intensity statins.

Authors:  Jeehoon Kang; Young-Chan Kim; Jin Joo Park; Sehun Kim; Si-Hyuck Kang; Young Jin Cho; Yeonyee E Yoon; Il-Young Oh; Chang-Hwan Yoon; Jung-Won Suh; Young-Seok Cho; Tae-Jin Youn; In-Ho Chae; Dong-Ju Choi
Journal:  Cardiovasc Diabetol       Date:  2018-01-11       Impact factor: 9.951

4.  Epicardial adipose tissue predicts incident cardiovascular disease and mortality in patients with type 2 diabetes.

Authors:  Regitse H Christensen; Bernt Johan von Scholten; Christian S Hansen; Magnus T Jensen; Tina Vilsbøll; Peter Rossing; Peter G Jørgensen
Journal:  Cardiovasc Diabetol       Date:  2019-08-30       Impact factor: 9.951

5.  Epicardial adipose tissue deposition in patients with diabetes and renal impairment: Analysis of the literature.

Authors:  Zoi Kleinaki; Aris P Agouridis; Maria Zafeiri; Theodoros Xanthos; Constantinos Tsioutis
Journal:  World J Diabetes       Date:  2020-02-15

Review 6.  Characterization of the inflammatory-metabolic phenotype of heart failure with a preserved ejection fraction: a hypothesis to explain influence of sex on the evolution and potential treatment of the disease.

Authors:  Milton Packer; Carolyn S P Lam; Lars H Lund; Mathew S Maurer; Barry A Borlaug
Journal:  Eur J Heart Fail       Date:  2020-06-26       Impact factor: 15.534

7.  Epicardial adipose tissue volume and coronary calcification among people living with diabetes: a cross-sectional study.

Authors:  Emmanuel Cosson; Minh Tuan Nguyen; Imen Rezgani; Sopio Tatulashvili; Meriem Sal; Narimane Berkane; Lucie Allard; Pierre-Yves Brillet; Hélène Bihan
Journal:  Cardiovasc Diabetol       Date:  2021-02-05       Impact factor: 9.951

8.  Epicardial adipose tissue volume and myocardial ischemia in asymptomatic people living with diabetes: a cross-sectional study.

Authors:  Emmanuel Cosson; Minh Tuan Nguyen; Imen Rezgani; Narimane Berkane; Sara Pinto; Hélène Bihan; Sopio Tatulashvili; Malak Taher; Meriem Sal; Michael Soussan; Pierre-Yves Brillet; Paul Valensi
Journal:  Cardiovasc Diabetol       Date:  2021-11-24       Impact factor: 9.951

9.  Characterization of different fat depots in NAFLD using inflammation-associated proteome, lipidome and metabolome.

Authors:  Alen Lovric; Marit Granér; Elias Bjornson; Muhammad Arif; Rui Benfeitas; Kristofer Nyman; Marcus Ståhlman; Markku O Pentikäinen; Jesper Lundbom; Antti Hakkarainen; Reijo Sirén; Markku S Nieminen; Nina Lundbom; Kirsi Lauerma; Marja-Riitta Taskinen; Adil Mardinoglu; Jan Boren
Journal:  Sci Rep       Date:  2018-09-21       Impact factor: 4.379

10.  Predictors of Epicardial Fat Volume Decrease after Dapagliflozin Treatment in Patients with Type 2 Diabetes.

Authors:  Adina Braha; Alin Albai; Bogdan Timar; Daniela Cipu; Lucian Vasiluță; Ovidiu Potre; Romulus Timar
Journal:  Medicina (Kaunas)       Date:  2021-12-23       Impact factor: 2.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.